HEADER TRANSFERASE 18-JAN-17 5MW4 TITLE CRYSTAL STRUCTURE OF DOT1L IN COMPLEX WITH INHIBITOR CPD7 [N-(3-(((R)- TITLE 2 1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-3-YL)(METHYL)AMINO) TITLE 3 PROPYL)-2-(3-(2-CHLORO-3-(2-METHYLPYRIDIN-3-YL)BENZO[B]THIOPHEN-5- TITLE 4 YL)UREIDO)ACETAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DOT1-LIKE PROTEIN,HISTONE H3-K79 METHYLTRANSFERASE,H3-K79- COMPND 5 HMTASE,LYSINE N-METHYLTRANSFERASE 4; COMPND 6 EC: 2.1.1.43; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DOT1L, KIAA1814, KMT4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, METHYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.BE,E.KOCH,C.GAUL,F.STAUFFER,H.MOEBITZ,C.SCHEUFLER REVDAT 2 05-APR-17 5MW4 1 JRNL REVDAT 1 22-MAR-17 5MW4 0 JRNL AUTH H.MOBITZ,R.MACHAUER,P.HOLZER,A.VAUPEL,F.STAUFFER,C.RAGOT, JRNL AUTH 2 G.CARAVATTI,C.SCHEUFLER,C.FERNANDEZ,U.HOMMEL,R.TIEDT, JRNL AUTH 3 K.S.BEYER,C.CHEN,H.ZHU,C.GAUL JRNL TITL DISCOVERY OF POTENT, SELECTIVE, AND STRUCTURALLY NOVEL DOT1L JRNL TITL 2 INHIBITORS BY A FRAGMENT LINKING APPROACH. JRNL REF ACS MED CHEM LETT V. 8 338 2017 JRNL REFN ISSN 1948-5875 JRNL PMID 28337327 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00519 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 54967 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2749 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.21 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3999 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2340 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3799 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE : 0.2820 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 200 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4899 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 277 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.67480 REMARK 3 B22 (A**2) : 7.67480 REMARK 3 B33 (A**2) : -15.34970 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.158 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.136 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.159 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.137 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5135 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6978 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1727 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 124 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 736 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5135 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 652 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5921 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.19 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* L|* } REMARK 3 ORIGIN FOR THE GROUP (A): 44.1748 -7.8684 8.2287 REMARK 3 T TENSOR REMARK 3 T11: -0.2250 T22: -0.1592 REMARK 3 T33: -0.1276 T12: 0.0191 REMARK 3 T13: -0.0310 T23: -0.0221 REMARK 3 L TENSOR REMARK 3 L11: 4.5436 L22: 3.9668 REMARK 3 L33: 0.6908 L12: -2.5199 REMARK 3 L13: 0.5169 L23: -0.3201 REMARK 3 S TENSOR REMARK 3 S11: -0.1649 S12: -0.4836 S13: -0.1164 REMARK 3 S21: 0.4670 S22: 0.2204 S23: -0.4781 REMARK 3 S31: -0.1383 S32: 0.1548 S33: -0.0555 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* M|* } REMARK 3 ORIGIN FOR THE GROUP (A): 35.2567 -37.3299 8.2700 REMARK 3 T TENSOR REMARK 3 T11: -0.1865 T22: -0.1969 REMARK 3 T33: -0.0305 T12: 0.0567 REMARK 3 T13: -0.0327 T23: 0.0282 REMARK 3 L TENSOR REMARK 3 L11: 3.5283 L22: 2.7118 REMARK 3 L33: 0.5866 L12: -1.2368 REMARK 3 L13: -0.9086 L23: 0.3053 REMARK 3 S TENSOR REMARK 3 S11: -0.0013 S12: -0.0762 S13: -0.2631 REMARK 3 S21: 0.0729 S22: -0.0863 S23: -0.4070 REMARK 3 S31: 0.2228 S32: 0.0234 S33: 0.0875 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MW4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200003106. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54968 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09700 REMARK 200 FOR THE DATA SET : 15.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 9.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1NW3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.92M LITHIUM SULFATE MONOHYDRATE, REMARK 280 0.1M AMMONIUM SULFATE, 0.1M SODIUM CITRATE TRIBASIC DIHYDRATE, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.29500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 37.29500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.29500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 PRO A 1 REMARK 465 GLY A 2 REMARK 465 GLU A 3 REMARK 465 LYS A 4 REMARK 465 THR A 92 REMARK 465 THR A 93 REMARK 465 GLN A 94 REMARK 465 PRO A 95 REMARK 465 MET A 96 REMARK 465 LYS A 97 REMARK 465 LEU A 98 REMARK 465 LEU A 125 REMARK 465 ASN A 126 REMARK 465 ASN A 127 REMARK 465 TYR A 128 REMARK 465 GLU A 129 REMARK 465 PRO A 130 REMARK 465 PHE A 131 REMARK 465 SER A 132 REMARK 465 PRO A 133 REMARK 465 GLU A 134 REMARK 465 VAL A 135 REMARK 465 TYR A 136 REMARK 465 GLY A 301 REMARK 465 SER A 302 REMARK 465 VAL A 303 REMARK 465 PRO A 332 REMARK 465 GLY A 333 REMARK 465 GLY B 0 REMARK 465 PRO B 1 REMARK 465 GLY B 2 REMARK 465 GLU B 3 REMARK 465 THR B 93 REMARK 465 GLN B 94 REMARK 465 PRO B 95 REMARK 465 MET B 96 REMARK 465 LYS B 97 REMARK 465 LEU B 98 REMARK 465 ASN B 126 REMARK 465 ASN B 127 REMARK 465 TYR B 128 REMARK 465 GLU B 129 REMARK 465 PRO B 130 REMARK 465 PHE B 131 REMARK 465 SER B 132 REMARK 465 PRO B 133 REMARK 465 GLU B 134 REMARK 465 VAL B 135 REMARK 465 TYR B 136 REMARK 465 PRO B 332 REMARK 465 GLY B 333 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 GLU A 69 CG CD OE1 OE2 REMARK 470 ARG A 73 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 ASN A 99 CG OD1 ND2 REMARK 470 THR A 120 OG1 CG2 REMARK 470 ASP A 121 CG OD1 OD2 REMARK 470 PRO A 122 CG CD REMARK 470 GLU A 123 CG CD OE1 OE2 REMARK 470 LYS A 124 CG CD CE NZ REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 THR A 139 OG1 CG2 REMARK 470 ASP A 189 CG OD1 OD2 REMARK 470 ILE A 190 CD1 REMARK 470 LYS A 193 CD CE NZ REMARK 470 ARG A 278 CD NE CZ NH1 NH2 REMARK 470 LYS A 300 CG CD CE NZ REMARK 470 SER A 304 OG REMARK 470 LYS B 4 CE NZ REMARK 470 LYS B 29 CG CD CE NZ REMARK 470 LYS B 66 CE NZ REMARK 470 GLU B 123 CG CD OE1 OE2 REMARK 470 LYS B 124 CE NZ REMARK 470 LEU B 125 CG CD1 CD2 REMARK 470 GLU B 138 CG CD OE1 OE2 REMARK 470 THR B 139 OG1 CG2 REMARK 470 LYS B 180 CD CE NZ REMARK 470 LYS B 193 CD CE NZ REMARK 470 LYS B 207 CD CE NZ REMARK 470 LYS B 261 CE NZ REMARK 470 ARG B 278 CG CD NE CZ NH1 NH2 REMARK 470 SER B 281 OG REMARK 470 ARG B 282 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 300 CG CD CE NZ REMARK 470 SER B 302 OG REMARK 470 VAL B 303 CG1 CG2 REMARK 470 SER B 304 OG REMARK 470 LYS B 330 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 61 -60.10 -102.16 REMARK 500 GLU A 138 -68.57 -133.56 REMARK 500 ILE B 61 -60.06 -101.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 652 DISTANCE = 6.23 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5JU A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5JU B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 403 DBREF 5MW4 A 2 332 UNP Q8TEK3 DOT1L_HUMAN 2 332 DBREF 5MW4 B 2 332 UNP Q8TEK3 DOT1L_HUMAN 2 332 SEQADV 5MW4 GLY A 0 UNP Q8TEK3 EXPRESSION TAG SEQADV 5MW4 PRO A 1 UNP Q8TEK3 EXPRESSION TAG SEQADV 5MW4 GLY A 333 UNP Q8TEK3 EXPRESSION TAG SEQADV 5MW4 GLY B 0 UNP Q8TEK3 EXPRESSION TAG SEQADV 5MW4 PRO B 1 UNP Q8TEK3 EXPRESSION TAG SEQADV 5MW4 GLY B 333 UNP Q8TEK3 EXPRESSION TAG SEQRES 1 A 334 GLY PRO GLY GLU LYS LEU GLU LEU ARG LEU LYS SER PRO SEQRES 2 A 334 VAL GLY ALA GLU PRO ALA VAL TYR PRO TRP PRO LEU PRO SEQRES 3 A 334 VAL TYR ASP LYS HIS HIS ASP ALA ALA HIS GLU ILE ILE SEQRES 4 A 334 GLU THR ILE ARG TRP VAL CYS GLU GLU ILE PRO ASP LEU SEQRES 5 A 334 LYS LEU ALA MET GLU ASN TYR VAL LEU ILE ASP TYR ASP SEQRES 6 A 334 THR LYS SER PHE GLU SER MET GLN ARG LEU CYS ASP LYS SEQRES 7 A 334 TYR ASN ARG ALA ILE ASP SER ILE HIS GLN LEU TRP LYS SEQRES 8 A 334 GLY THR THR GLN PRO MET LYS LEU ASN THR ARG PRO SER SEQRES 9 A 334 THR GLY LEU LEU ARG HIS ILE LEU GLN GLN VAL TYR ASN SEQRES 10 A 334 HIS SER VAL THR ASP PRO GLU LYS LEU ASN ASN TYR GLU SEQRES 11 A 334 PRO PHE SER PRO GLU VAL TYR GLY GLU THR SER PHE ASP SEQRES 12 A 334 LEU VAL ALA GLN MET ILE ASP GLU ILE LYS MET THR ASP SEQRES 13 A 334 ASP ASP LEU PHE VAL ASP LEU GLY SER GLY VAL GLY GLN SEQRES 14 A 334 VAL VAL LEU GLN VAL ALA ALA ALA THR ASN CYS LYS HIS SEQRES 15 A 334 HIS TYR GLY VAL GLU LYS ALA ASP ILE PRO ALA LYS TYR SEQRES 16 A 334 ALA GLU THR MET ASP ARG GLU PHE ARG LYS TRP MET LYS SEQRES 17 A 334 TRP TYR GLY LYS LYS HIS ALA GLU TYR THR LEU GLU ARG SEQRES 18 A 334 GLY ASP PHE LEU SER GLU GLU TRP ARG GLU ARG ILE ALA SEQRES 19 A 334 ASN THR SER VAL ILE PHE VAL ASN ASN PHE ALA PHE GLY SEQRES 20 A 334 PRO GLU VAL ASP HIS GLN LEU LYS GLU ARG PHE ALA ASN SEQRES 21 A 334 MET LYS GLU GLY GLY ARG ILE VAL SER SER LYS PRO PHE SEQRES 22 A 334 ALA PRO LEU ASN PHE ARG ILE ASN SER ARG ASN LEU SER SEQRES 23 A 334 ASP ILE GLY THR ILE MET ARG VAL VAL GLU LEU SER PRO SEQRES 24 A 334 LEU LYS GLY SER VAL SER TRP THR GLY LYS PRO VAL SER SEQRES 25 A 334 TYR TYR LEU HIS THR ILE ASP ARG THR ILE LEU GLU ASN SEQRES 26 A 334 TYR PHE SER SER LEU LYS ASN PRO GLY SEQRES 1 B 334 GLY PRO GLY GLU LYS LEU GLU LEU ARG LEU LYS SER PRO SEQRES 2 B 334 VAL GLY ALA GLU PRO ALA VAL TYR PRO TRP PRO LEU PRO SEQRES 3 B 334 VAL TYR ASP LYS HIS HIS ASP ALA ALA HIS GLU ILE ILE SEQRES 4 B 334 GLU THR ILE ARG TRP VAL CYS GLU GLU ILE PRO ASP LEU SEQRES 5 B 334 LYS LEU ALA MET GLU ASN TYR VAL LEU ILE ASP TYR ASP SEQRES 6 B 334 THR LYS SER PHE GLU SER MET GLN ARG LEU CYS ASP LYS SEQRES 7 B 334 TYR ASN ARG ALA ILE ASP SER ILE HIS GLN LEU TRP LYS SEQRES 8 B 334 GLY THR THR GLN PRO MET LYS LEU ASN THR ARG PRO SER SEQRES 9 B 334 THR GLY LEU LEU ARG HIS ILE LEU GLN GLN VAL TYR ASN SEQRES 10 B 334 HIS SER VAL THR ASP PRO GLU LYS LEU ASN ASN TYR GLU SEQRES 11 B 334 PRO PHE SER PRO GLU VAL TYR GLY GLU THR SER PHE ASP SEQRES 12 B 334 LEU VAL ALA GLN MET ILE ASP GLU ILE LYS MET THR ASP SEQRES 13 B 334 ASP ASP LEU PHE VAL ASP LEU GLY SER GLY VAL GLY GLN SEQRES 14 B 334 VAL VAL LEU GLN VAL ALA ALA ALA THR ASN CYS LYS HIS SEQRES 15 B 334 HIS TYR GLY VAL GLU LYS ALA ASP ILE PRO ALA LYS TYR SEQRES 16 B 334 ALA GLU THR MET ASP ARG GLU PHE ARG LYS TRP MET LYS SEQRES 17 B 334 TRP TYR GLY LYS LYS HIS ALA GLU TYR THR LEU GLU ARG SEQRES 18 B 334 GLY ASP PHE LEU SER GLU GLU TRP ARG GLU ARG ILE ALA SEQRES 19 B 334 ASN THR SER VAL ILE PHE VAL ASN ASN PHE ALA PHE GLY SEQRES 20 B 334 PRO GLU VAL ASP HIS GLN LEU LYS GLU ARG PHE ALA ASN SEQRES 21 B 334 MET LYS GLU GLY GLY ARG ILE VAL SER SER LYS PRO PHE SEQRES 22 B 334 ALA PRO LEU ASN PHE ARG ILE ASN SER ARG ASN LEU SER SEQRES 23 B 334 ASP ILE GLY THR ILE MET ARG VAL VAL GLU LEU SER PRO SEQRES 24 B 334 LEU LYS GLY SER VAL SER TRP THR GLY LYS PRO VAL SER SEQRES 25 B 334 TYR TYR LEU HIS THR ILE ASP ARG THR ILE LEU GLU ASN SEQRES 26 B 334 TYR PHE SER SER LEU LYS ASN PRO GLY HET 5JU A 401 45 HET SO4 A 402 5 HET SO4 A 403 5 HET 5JU B 401 45 HET SO4 B 402 5 HET SO4 B 403 5 HETNAM 5JU N~2~-{[2-CHLORO-3-(2-METHYLPYRIDIN-3-YL)-1- HETNAM 2 5JU BENZOTHIOPHEN-5-YL]CARBAMOYL}-N-(3-{METHYL[(3R)-1-(5H- HETNAM 3 5JU PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-3- HETNAM 4 5JU YL]AMINO}PROPYL)GLYCINAMIDE HETNAM SO4 SULFATE ION FORMUL 3 5JU 2(C32 H36 CL N9 O2 S) FORMUL 4 SO4 4(O4 S 2-) FORMUL 9 HOH *277(H2 O) HELIX 1 AA1 ALA A 33 ILE A 48 1 16 HELIX 2 AA2 ILE A 48 MET A 55 1 8 HELIX 3 AA3 GLU A 56 ILE A 61 5 6 HELIX 4 AA4 SER A 67 GLY A 91 1 25 HELIX 5 AA5 SER A 103 VAL A 119 1 17 HELIX 6 AA6 GLU A 138 LYS A 152 1 15 HELIX 7 AA7 GLY A 167 THR A 177 1 11 HELIX 8 AA8 ALA A 188 GLY A 210 1 23 HELIX 9 AA9 SER A 225 ASN A 234 1 10 HELIX 10 AB1 GLY A 246 ALA A 258 1 13 HELIX 11 AB2 ASP A 286 THR A 289 5 4 HELIX 12 AB3 ARG A 319 ASN A 331 1 13 HELIX 13 AB4 ASP B 32 ILE B 48 1 17 HELIX 14 AB5 ILE B 48 MET B 55 1 8 HELIX 15 AB6 GLU B 56 ILE B 61 5 6 HELIX 16 AB7 SER B 67 THR B 92 1 26 HELIX 17 AB8 SER B 103 VAL B 119 1 17 HELIX 18 AB9 GLU B 138 ILE B 151 1 14 HELIX 19 AC1 GLY B 167 THR B 177 1 11 HELIX 20 AC2 ALA B 188 GLY B 210 1 23 HELIX 21 AC3 SER B 225 ASN B 234 1 10 HELIX 22 AC4 GLY B 246 ALA B 258 1 13 HELIX 23 AC5 ASP B 286 THR B 289 5 4 HELIX 24 AC6 ARG B 319 ASN B 331 1 13 SHEET 1 AA1 2 GLU A 6 LEU A 9 0 SHEET 2 AA1 2 ALA A 18 PRO A 21 -1 O TYR A 20 N LEU A 7 SHEET 1 AA2 2 VAL A 26 ASP A 28 0 SHEET 2 AA2 2 HIS A 31 ASP A 32 -1 O HIS A 31 N ASP A 28 SHEET 1 AA3 7 TYR A 216 ARG A 220 0 SHEET 2 AA3 7 HIS A 181 GLU A 186 1 N GLY A 184 O GLU A 219 SHEET 3 AA3 7 LEU A 158 LEU A 162 1 N PHE A 159 O TYR A 183 SHEET 4 AA3 7 VAL A 237 VAL A 240 1 O PHE A 239 N VAL A 160 SHEET 5 AA3 7 ARG A 265 SER A 268 1 O VAL A 267 N ILE A 238 SHEET 6 AA3 7 TYR A 312 ILE A 317 -1 O HIS A 315 N ILE A 266 SHEET 7 AA3 7 MET A 291 LEU A 296 -1 N LEU A 296 O TYR A 312 SHEET 1 AA4 2 GLU B 6 LEU B 9 0 SHEET 2 AA4 2 ALA B 18 PRO B 21 -1 O TYR B 20 N LEU B 7 SHEET 1 AA5 7 TYR B 216 ARG B 220 0 SHEET 2 AA5 7 HIS B 181 GLU B 186 1 N GLY B 184 O GLU B 219 SHEET 3 AA5 7 LEU B 158 LEU B 162 1 N PHE B 159 O TYR B 183 SHEET 4 AA5 7 VAL B 237 VAL B 240 1 O PHE B 239 N VAL B 160 SHEET 5 AA5 7 ARG B 265 SER B 268 1 O VAL B 267 N ILE B 238 SHEET 6 AA5 7 TYR B 312 ILE B 317 -1 O HIS B 315 N ILE B 266 SHEET 7 AA5 7 MET B 291 LEU B 296 -1 N LEU B 296 O TYR B 312 CISPEP 1 TRP A 22 PRO A 23 0 2.68 CISPEP 2 TRP B 22 PRO B 23 0 -2.44 SITE 1 AC1 21 SER A 140 LEU A 143 VAL A 144 ASP A 161 SITE 2 AC1 21 GLY A 163 SER A 164 GLY A 165 VAL A 169 SITE 3 AC1 21 GLU A 186 LYS A 187 GLY A 221 ASP A 222 SITE 4 AC1 21 PHE A 223 PHE A 239 VAL A 240 ASN A 241 SITE 5 AC1 21 VAL A 267 SER A 268 SER A 269 SER A 311 SITE 6 AC1 21 HOH A 511 SITE 1 AC2 2 ASN A 79 ARG A 80 SITE 1 AC3 3 THR A 100 ARG A 101 LYS A 212 SITE 1 AC4 21 SER B 140 LEU B 143 VAL B 144 ASP B 161 SITE 2 AC4 21 GLY B 163 SER B 164 GLY B 165 VAL B 169 SITE 3 AC4 21 GLU B 186 LYS B 187 GLY B 221 ASP B 222 SITE 4 AC4 21 PHE B 223 PHE B 239 VAL B 240 ASN B 241 SITE 5 AC4 21 VAL B 267 SER B 268 SER B 269 SER B 311 SITE 6 AC4 21 HOH B 506 SITE 1 AC5 4 ARG B 8 LYS B 10 ASN B 79 ARG B 80 SITE 1 AC6 3 THR B 100 ARG B 101 LYS B 212 CRYST1 158.360 158.360 74.590 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006315 0.003646 0.000000 0.00000 SCALE2 0.000000 0.007292 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013407 0.00000 MASTER 420 0 6 24 20 0 16 6 0 0 0 52 END